Discussions are in first half of 2014 as Insmed stated. I haven't seen, nor can you proove, that discussions are going to Sept. 2014. Nice try, Terry.
Terry. The word "Ignore" means the same to you as "fact". It means not to be used!
I sure Bo is shakin in his boots since you reported him. Terry & Kinky are really the cutest couple when it comes to covering each other's backside. Neither can tell the truth, much less present facts. Honesty just isn't part of your makeup. Both of you would rather lie, cheat, or steal to make a buck, with emphasis on lying.
It's quite amazing to watch you two work in tandem to present half truths, contort facts, and add BS to satisfy your greed. Good job. Your bosses should be happy with a bunch of Losers like you two.
You would think that November 2013 and February 2014 Investor Presentations give an updated and clearer picture of their discussions with the FDA than October 2013.
Continuation of PR:
W. John Short, CEO & President of RBT commented "Natural Products Expo West provides an excellent opportunity to highlight the enhanced capabilities resulting from our recent acquisition of H&N Distribution. In addition to delivering our individual functional ingredients, we are now in a position to provide turnkey, packaged finished product offerings to a variety of retail, direct-to-consumer and direct marketing customers based on our proprietary and patented ingredients blended with other sources of proteins and phytonutrients to produce healthy and natural products that compete effectively in the health and wellness markets."
On January 2, 2014 RBT acquired H&N Distribution, Inc. ("H&N"), a formulator and co-packer of healthy and natural products for the direct marketing, internet sales and retail distribution markets both domestically and internationally. H&N founder Mark McKnight has completed his relocation to RBT's corporate headquarters in Scottsdale, Arizona and has taken the roles of Senior Vice President of Contract Manufacturing and a member of RBT's Senior Management Committee while retaining his position as President of RBT's H&N subsidiary
SCOTTSDALE, Arizona, February 25, 2014 /PRNewswire/ --
RiceBran Technologies (RIBT) and (RIBTW) ("RBT"), a global leader in the production and marketing of value added products derived from rice bran, today announced that RBT is exhibiting at Booth #8623 at the upcoming Natural Products Expo West trade show from March 7 to March 9, 2014 at the Anaheim Convention Center in Anaheim, California.
RBT will exhibit its range of minimally processed, hypo-allergenic, gluten free, non-GMO stabilized rice bran ingredients and patented rice bran derivatives at Natural Products Expo West, the leading trade show in the natural, organic and healthy products industry. Natural Products Expo West is expected to attract over 60,000 industry professionals and 3,000 exhibitors to the Anaheim Convention Center.
Dr. Robert Smith, SVP of Sales and Business Development for RBT commented, "Based on growing consumer demand for highly nutritious, gluten-free, vegan and minimally processed products, Natural Products Expo West is the ideal venue for exhibiting our proprietary and patented rice bran and derivative products. We will be highlighting the health and nutritional benefits that can be achieved by incorporating our ingredients into a diverse range of healthy foods from beverages, nutrition bars, cereals, and pastas to high-end companion pet nutrition products....
Terry. Go back and read the November 2013 Investor presentation on page 24. Under 2014's heading of 1st Half, it states: "NTM Data and FDA dialogue". I don't know how book smart you are, but dialogue and discussion seem to have the same meaning. Insmed stated it would be in the first 6 months of 2014, which is January to June for the FDA dialogue and/or discussion, not "BY THE END of the first quarter NOW"
The only things you nailed are the presentation of false facts again and the manifestation of your agenda.
Dorian. I'm not sure he will need a lawyer. I think this guy is Peggy from the Discover Card commercial that resides in Russia on the Call Center customer center phone lines. It's obvious he can't spell or write clearly.
How about providing a link, or copy and paste, or some article that proves your statement. They are called facts. Please inform us. It's not that we don't want to take your word, but facts are much better.
Will Lewis said by midyear. I take that as June-July or 4-5 months. On page 17 in February 2014 Investor Presentation under Key Takaways and Two Near Term Commercial Opportunities, it states: Europe:
Arikace EMA filing for CF in 1st Half 2014.
On page 24 of November 2013 Investor Presentation, under 1st Half 2014, it states, "Estimated Filing for CF Indication in Europe/Canada.
I don't read that as a delay, but I don't have an agenda like you. It doesn't mention Japan in either of those. If they get it great, but it may not be the priority now. Your immaturity is overwhelming this board. Your like the little kid in the schoolyard stating "I know you are, but what am I?"
Your problem is you don't know the difference between fact and fiction, and you couldn't provide Facts even if you wanted. The #$%$ is the stuff on your face thats replaces the egg.
Hey Terry, read it again. Last word from Lewis says "midyear" You are one lying FOS Loser!!!
Further, we believe that
once-daily administration of ARIKACE will support patient convenience and compliance,” said Will Lewis, President and Chief Executive
Officer of Insmed. “With the results achieved in our Phase 3 trial, along with these positive interim data, we continue our preparation for
regulatory filings with the European Medicines Agency and Health Canada, which remain on target for mid-year.”
140 Ids. The challenge was to prove the" Pohaler results" were better in their Phase III results, and that "durability is overblown" Surely you have some statistical data to prove the "overblown" statement. Or are you just taking your head out of your orifice for a breather, and saying the first thing that comes to mind.